Microarray Analysis Market Outlook

In 2021, the microarray analysis market was valued at $3,846.7 million. Which is on the track to touching $9,011.1 million worth by 2030.  Advancing at a 9.9% CAGR from 2021 to 2030. The market is primarily driven by the surging incidence of cancer, government-sponsored genomic and proteomic research projects, and increasing use of microarrays.

To stay competitive, the major microarray analysis market players are taking part in several strategic initiatives, including product launches and acquisitions. These key players are Applied Microarrays LLC, Arrayit Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Microarrays Inc., Merck KGaA, GE Healthcare, Illumina Inc., and Agilent Technologies Inc.

Market Driven by Growing Use of Microarrays in Non-Cancer Applications

Given that bacterial genomic DNA often outlives the actual bacteria in most circumstances, microarray analysis has proven effective in antibiotic treatment. Since a diagnosis may be made using a small amount of DNA, rather than the large number of bacteria needed for a culture in these situations, DNA microarrays are frequently used.

For assessing gene expression, DNA-based microarrays have recently taken the lead. This is primarily driven by the technology’s lower cost and complexity of use, which enable it to be standardized and more accepted.

Regional Insights

  • North America held an almost 40% share of the microarray analysis market in 2021. Because the governments of the U.S. and Canada are consistently increasing their funds for cancer research, the region is expected to experience significant growth in the coming years.
  • Furthermore, due to its highly developed healthcare sector, cutting-edge R&D infrastructure, and availability of the related products, Europe is the largest market after North America.

Segmentation Insights

  • Based on product and service, consumables will advance with over 10% CAGR between 2021 and 2030, due to the increasing number of research institutes and rising usage of microarray analysis at diagnostic laboratories.
  • The software & services category generates the third-highest revenue, as software is extensively utilized to analyze and identify genomes, by studying the data generated during the study.
  • Globally, DNA microarrays accounted for the biggest market share in 2021, and their revenue contribution is expected to grow at a CAGR of almost 10% in the coming years. This is because a variety of disorders have clinical diagnostic procedures that employ DNA microarrays.
  • In 2021, the largest share of the microarray analysis market was held by research and academic institutes, and by 2030, these users would acquire associated products worth over $4.0 billion. This is because the number of projects studying the human genome has increased recently.
  • Similarly, rapid market growth is expected from pharmaceutical and biotechnology firms as a result of the numerous research projects they are conducting for the creation of new medications.

Browse More Reports Published by P&S

Protein A Resin Market Size, Share, Trends and Forecast to 2030

Public and private organizations are making huge investments in protein-based research and development (R&D). In recent past, the development of monoclonal antibodies and proteins as therapeutic agents was avoided by pharmaceutical firms, on account of their size, poor delivery, low stability, and rate of degradation. However, the companies are focusing on the development of proteins and monoclonal antibodies as therapeutics to address the unmet requirements in several therapeutic areas, including oncology, metabolic diseases, cardiovascular disorders, and infectious diseases. This has increased the usage of proteins that imitate the functions of mediators.

The increasing R&D activities along with surging burden of chronic diseases and booming geriatric population will drive the protein A resin market at 7.0% CAGR during 2020–2030. The market was valued at $486.4 million in 2019, and it is expected to generate $1,020.7 million by 2030. According to the United Nations Population Fund, around 22% of global population will aged 60 years or above by 2050. The elderly more vulnerable to chronic diseases and rising cases of such ailments would boost the demand for new protein-based therapeutic agents for disease management.

https://www.psmarketresearch.com/market-analysis/protein-a-resin-market

DNA Extraction Kit Market Share and Growth Analysis, 2030

The size of the DNA extraction kit market was about $1,354 million in 2021 . Will grow at a rate of around 9% by the end of this decade. To reach a value of about $2,818 million by 2030. The growth can be because of the rising research actions in consort with technological progressions in healthcare facilities, forensic sciences, and the growing investments in R&D activities, for fields like molecular diagnostics for numerous chronic and communicable diseases.

The requirement for DNA extraction kits for NGS purposes will rise at the highest growth rate of around 10%. In the years to come in the DNA extraction kit market. Early cancer diagnosis and other genetic ailments are the biggest challenges for scholars, and therefore. Numerous experiments are conducted. For the analysis of genetic disorders, next-gen sequencing is extensively used to confront this problem.

https://www.psmarketresearch.com/market-analysis/dna-extraction-kit-market

Gene Therapy Market Size, Share, and Revenue Estimation Through 2030

The global gene therapy market reached a value of $3,407.5 million in 2019. It is predicted to register a CAGR of 31.1% during the forecast period 2020–2030, as per a report by P&S Intelligence. The market is registering considerable growth due to the rising number of research activities that are being carried out in the domain. An increasing number of private and public companies are engaging in research in the domain.

Despite the sheer complexity of the process, various novel technologies are being utilized in the current gene editing models. Furthermore, the rising number of clinical trials with stem cells are also resulting in the increasing gene therapy research activities. The focus of research studies is on the development of experimental vectors. Increasing the efficiency of treatment, improving the specificity of delivery systems, and improving the understanding of the inflammatory response.

https://www.psmarketresearch.com/market-analysis/gene-therapy-market

Particle Therapy Market Size, Share, Growth and Demand Forecast to 2030

The major drivers in the global particle therapy market are the rising count of particle therapy centers. The swift integration of this therapy for cancer treatment. In 2021, the sales revenue of the products used for such treatments stood at $797.1 million. It is predicted to touch $1,634.4 million by 2030. The market will advance at an 8.3% CAGR from 2021 to 2030. Additionally, the highly competitive market players continuously participate in mergers and acquisitions for not only the swift deployment of technologically advanced devices but also for the development of new products in the market. Therefore, all of this will amplify the market growth.

Within the type segment, the particle therapy market can be bifurcated into heavy ion therapy and proton therapy. Accounting for more than 90% of the total market share, the latter bifurcation is projected to exhibit the same trend in the coming years as well. Advancing at an 8.5% CAGR. This can be attributed to the extensive utilization of this therapy for several cancer treatments, such as breast cancer. Brain tumor, and pediatric cancer.

https://www.psmarketresearch.com/market-analysis/particle-therapy-market

The research offers the size of the global microarray analysis market for the period 2017–2030.

Product and Service

  • Consumables
  • Instruments
  • Software & Services

Type

  • DNA
  • Protein
  • Others

Application

  • Research
  • Drug Discovery
  • Diagnostics
  • Others

End User

  • Research & Academic Institutes
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Others

Region

  • North America Microarray Analysis Market
    • By product and service
    • By type
    • By application
    • By end user
    • By country – U.S. and Canada
  • Europe Microarray Analysis Market
    • By product and service
    • By type
    • By application
    • By end user
    • By country – U.K., Germany, France, Spain, Italy, and Rest of Europe
  • Asia-Pacific (APAC) Microarray Analysis Market
    • By product and service
    • By type
    • By application
    • By end user
    • By country – China, India, Japan, and Rest of APAC
  • Latin America (LATAM) Microarray Analysis Market
    • By product and service
    • By type
    • By application
    • By end user
    • By country – Brazil, Mexico, and Rest of LATAM
  • Middle East and Africa (MEA) Microarray Analysis Market
    • By product and service
    • By type
    • By application
    • By end user
    • By country – Saudi Arabia, South Africa, and Rest of MEA

 

Above all,most importantly,
certainly,That is to say,
in other words,to clarify,
Therefore,as a result,
so,consequently,
In conclusion,to sum up,
in short
Above all,most importantly,
certainly,That is to say,
in other words,to clarify,
Therefore,as a result,
so,consequently,
In conclusion,to sum up,
in short
Above all,most importantly,
certainly,That is to say,
in other words,to clarify,
Therefore,as a result,
so,consequently,
In conclusion,to sum up,
in short
Above all,most importantly,
certainly,That is to say,
in other words,to clarify,
Therefore,as a result,
so,consequently,
In conclusion,to sum up,
in short

LEAVE A REPLY

Please enter your comment!
Please enter your name here